Advancements in Sepsis Management: Biomarker-Guided Antibiotic Therapy

Join us for an insightful scientific webinar on advancements in sepsis management and reflections on the ADAPT Sepsis trial.

Join us for an insightful scientific webinar on "Advancements in Sepsis Management: Biomarker-Guided Antibiotic Therapy," where we will delve into the groundbreaking findings from the recent study on biomarker-guided antibiotic duration for patients with suspected sepsis. This study, conducted across multiple UK hospitals, explores the efficacy of using biomarkers such as Procalcitonin (PCT) and C-Reactive Protein (CRP) to guide the duration of antibiotic therapy in sepsis management.

 

Learning Objectives:

  1. Introduction to Sepsis and Antibiotic Stewardship: Understand the critical impact of sepsis and the importance of optimizing antibiotic use to prevent resistance.
  2. Role of Biomarkers in Sepsis: Discover how biomarkers like PCT and CRP can enhance the accuracy and efficiency of sepsis treatment.
  3. Study Design and Results: Gain insights into the methodology, patient selection, and key findings of the clinical trial, including its impact on mortality rates, hospital stay duration, and antibiotic usage.
  4. Clinical Implications and Future Directions: Explore the challenges of implementing biomarker-guided therapy and potential future research directions.

Speakers

Professor Paul Dark

Professor Paul Dark

Find out more